| Name | Circassia Group |
|---|---|
| Epic | CIR |
| Isin | GB00BJVD3B28 |
| Index | AIM100 AIM350 |
| Industry | Medical Equipment and Services |
| Latest share price | 34.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £142.66 | Debt ratio | n/a |
| Shares in issue | 419.53 | Debt-to-equity ratio | n/a |
| P/E ratio | 40.6 | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -6.19 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | 1 | 52-week high / low | 29.00p / 46.05p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Circassia Group |
|---|---|
| Address | Hayakawa Building, Edmund Halley Road, Oxford Science Park, Oxford, United Kingdom, OX4 4GB |
| Telephone | +44 (0)1865 405560 |
| Website | http://www.circassia.co.uk |
| Director | Position |
|---|---|
| Mr Nicholas Mills | Non-Executive Director |
| Mr Ian Johnson | Executive Chairman |
| Mr Garry Watts | Senior Independent Director |
| Mr Michael R D Roller | Chief Finance Officer |
| Mr Jo Le Couilliard | Independent Non-Executive Director |
| Mr Sharon Curran | Independent Non-Executive Director |
| Mr Jonathan Emms | Chief Operating Officer |
| Assets £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Reporting date | 31/12/21 | 31/12/20 | 31/12/19 |
| Intangible asssets and goodwill | 42.1 | 50.4 | 167.8 |
| Investments and other non-current assets | n/a | n/a | n/a |
| Total non-current assets | 66.6 | 73.4 | 198.5 |
| Inventory / work in progress | 2.7 | 4 | 6.5 |
| Trade and other receivables | 4.5 | 18.3 | 14.6 |
| Cash and equivalents | 12.6 | 7.4 | 27 |
| Other current assets and asset held for resale | n/a | n/a | 0.2 |
| Total of all assets | 86.4 | 103.1 | 246.8 |
| Liabilities £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Short term liabilities | 10.8 | 26.7 | 41.3 |
| Long term liabilities | 8.8 | 10.3 | 120.7 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 19.6 | 37 | 162 |
| Net assets £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Net assets | 66.8 | 66.1 | 84.8 |
| Equity £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Share capital | 0.3 | 0.3 | 0.3 |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | -590.5 | -594.1 | -560.6 |
| Share premium account | 640.3 | 635.4 | 630.4 |
| Total equity | 66.8 | 66.1 | 84.8 |
| Income £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -4.3 | -17.3 | -63.8 |
| Pre-tax profit | -2.1 | -18.4 | -27.6 |